Despite advances in surgical techniques, recurrence rates after endoscopic sinus surgery (ESS) for chronic rhinosinusitis with nasal polyps (CRSwNP) remain high and difficult to predict.
Objective
This study aimed to evaluate the potential role of microRNA 125b (miR-125b) in predicting disease evolution following ESS.
Methods
We conducted a prospective study including patients undergoing first ESS for CRSwNP in our department between January 2020 and November 2021. We determined miR-125b levels from nasal polyps and pursued a standardized follow-up for at least 18 months for each patient.
Results
A total of 86 patients were included in the study. Higher postoperative endoscopy scores were associated with more severe disease at presentation on computed tomography scan, presence of concomitant asthma, and higher values of miR-125b. Even after multivariate repeated measures analysis and adjustments for confounders, miR-125b remained statistically significant. Moreover, miR-125 was the most important factor in predicting disease evolution at 18 months.
Conclusion
A clear, robust relation between nasal polyp control evaluated through objective measures and miR-125b values was observed. This finding indicates the potential role of miR-125b in predicting the course of the disease following ESS.
FokkensWJLundVJHopkinsC, et al.European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(Suppl S29):1-464. doi:https://doi.org/10.4193/Rhin20.600
2.
DeCondeASMaceJCLevyJMRudmikLAltJASmithTL. Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis. Laryngoscope. 2017;127(3):550-555. doi:https://doi.org/10.1002/lary.26391
3.
SellaGCPTamashiroESellaJA, et al.Asthma is the dominant factor for recurrence in chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2020;8(1):302-309. doi:https://doi.org/10.1016/j.jaip.2019.08.007
4.
AlbuSTomescuEMexcaZ, et al.Recurrence rates in endonasal surgery for polyposis. Acta Otorhinolaryngol Belg. 2004;58:79-86.
5.
SmithTLMendolia-LoffredoSLoehrlTA, et al.Predictive factors and outcomes in endoscopic sinus surgery for chronic rhinosinusitis. Laryngoscope. 2005;115(12):2199-2205. doi:https://doi.org/10.1097/01.mlg.0000182825.82910.80
6.
SmithKAOrlandiRROakleyGMeeksHCurtinKAltJA. Long-term revision rates for endoscopic sinus surgery. Int Forum Allergy Rhinol. 2019;9(4):402-408. doi:https://doi.org/10.1002/alr.22264
7.
Van ZeleTHoltappelsGGevaertPBachertC. Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy. 2014;28(3):192-198. doi:https://doi.org/10.2500/ajra.2014.28.4033
8.
MortuaireGGenglerICarpentierCSzymanskiCChenivesseCLefevreG. T helper 2 inflammatory markers are associated with recurrence in chronic rhinosinusitis with nasal polyps after endoscopic sinus surgery. Rhinology. 2020;58(5):444-450. doi:https://doi.org/10.4193/Rhin19.439
9.
RosatiDRosatoCPagliucaG, et al.Predictive markers of long-term recurrence in chronic rhinosinusitis with nasal polyps. Am J Otolaryngol. 2020;41(1):102286. doi:https://doi.org/10.1016/j.amjoto.2019.102286
10.
DeCondeASSuhJDMaceJCAltJASmithTL. Outcomes of complete vs targeted approaches to endoscopic sinus surgery. Int Forum Allergy Rhinol. 2015;5(8):691-700. doi:https://doi.org/10.1002/alr.21541
11.
SeahJJThongMWangY. The diagnostic and prognostic role of biomarkers in chronic rhinosinusitis. Diagnostics (Basel). 2023;13(4):715. doi:https://doi.org/10.3390/diagnostics13040715
XiaGBaoLGaoWLiuSJiKLiJ. Differentially expressed miRNA in inflammatory mucosa of chronic rhinosinusitis. J Nanosci Nanotechnol. 2015;15(3):2132-2139. doi:https://doi.org/10.1166/jnn.2015.9161
17.
ZhangXHZhangYNLiHB, et al.Overexpression of miR-125b, a novel regulator of innate immunity, in eosinophilic chronic rhinosinusitis with nasal polyps. Am J Respir Crit Care Med. 2012;185(2):140-151. doi:https://doi.org/10.1164/rccm.201103-0456OC
18.
SongLWangXQuXLvC. Transcription factor specificity protein 1 regulates inflammation and fibrin deposition in nasal polyps via the regulation of microRNA-125b and the Wnt/β-catenin signaling pathway. Inflammation. 2022;45(3):1118-1132. doi:https://doi.org/10.1007/s10753-021-01605-w
19.
GataANeagoeIBLeucutaDC, et al.MicroRNAs: potential biomarkers of disease severity in chronic rhinosinusitis with nasal polyps. Medicina (Kaunas). 2023;59(3):550. doi:https://doi.org/10.3390/medicina59030550
20.
FokkensWJLundVJMullolJ, et al.EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50(1):1-12. doi:https://doi.org/10.4193/Rhino12.000
21.
LundVJMackayIS. Staging in rhinosinusitus. Rhinology. 1993;31(4):183-184.
22.
LildholdtTRundcrantzHLindqvistN. Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide. Clin Otolaryngol Allied Sci. 1995;20(1):26-30. doi:https://doi.org/10.1111/j.1365-2273.1995.tb00007.x
23.
WrightEDAgrawalS. Impact of perioperative systemic steroids on surgical outcomes in patients with chronic rhinosinusitis with polyposis: evaluation with the novel Perioperative Sinus Endoscopy (POSE) scoring system. Laryngoscope. 2007;117(S115):1-28. doi:https://doi.org/10.1097/MLG.0b013e31814842f8
24.
YuJKangXXiongYLuoQDaiDYeJ. Gene expression profiles of circular RNAs and MicroRNAs in chronic rhinosinusitis with nasal polyps. Front Mol Biosci. 2021;8(1):643504. doi:https://doi.org/10.3389/fmolb.2021.643504
McHughTSnidvongsKXieMBanglawalaSSommerD. High tissue eosinophilia as a marker to predict recurrence for eosinophilic chronic rhinosinusitis: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2018;8(12):1421-1429. doi:https://doi.org/10.1002/alr.22194
27.
LouHZhangNBachertCZhangL. Highlights of eosinophilic chronic rhinosinusitis with nasal polyps in definition, prognosis, and advancement. Int Forum Allergy Rhinol. 2018;8(11):1218-1225. doi:https://doi.org/10.1002/alr.22214
28.
BresciaGMarioniGFranchellaS, et al.Can a panel of clinical, laboratory, and pathological variables pinpoint patients with sinonasal polyposis at higher risk of recurrence after surgery?Am J Otolaryngol. 2015;36(4):554-558. doi:https://doi.org/10.1016/j.amjoto.2015.01.019
29.
HopkinsCSlackRLundVBrownPCopleyLBrowneJ. Long-term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis. Laryngoscope. 2009;119(12):2459-2465. doi:https://doi.org/10.1002/lary.20653
30.
JankowskiRPigretDDecroocqF, et al.Comparison of radical (nasalisation) and functional ethmoidectomy in patients with severe sinonasal polyposis. A retrospective study. Rev Laryngol Otol Rhinol (Bord). 2006;127(3):131-140.
31.
WuAWTingJYPlattMPTierneyHTMetsonR. Factors affecting time to revision sinus surgery for nasal polyps: a 25-year experience. Laryngoscope. 2014;124(1):29-33. doi:https://doi.org/10.1002/lary.24213
